Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Steady Progress Toward Continuous Flow API Synthesis

The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.
Aug 4, 2014

The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.

Acute Need for Supply Chain Transparency

Biopharma manufacturers must reduce the risk in their complex supply chains
Aug 4, 2014

Biopharma manufacturers must reduce the risk in their complex supply chains

Pharma Investments Reflect Key Industry Trends

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Aug 2, 2014

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

Customers are looking to reduce risk, increase performance, and optimize productivity.
Aug 2, 2014

Customers are looking to reduce risk, increase performance, and optimize productivity.

The Mainstreaming of Continuous Flow API Synthesis

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.
Jul 2, 2014

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.

Automating Online Sampling of Bioprocesses

The Modular Automated Sampling Technology platform consists of a sterile sampling system, a sample scheduler and navigator for automated sampling and delivery of samples to analytical instruments, and a data-management system.
Jul 2, 2014

The Modular Automated Sampling Technology platform allows sampling of bioreactors.

Advances in Real-Time Bioreactor Sampling

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.
Jun 18, 2014

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.

Seeking Alternative Catalyst Solutions

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.
Jun 2, 2014

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

Alternatives to Precious Metal Catalysts Sought

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.
Jun 2, 2014

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here